The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes
Journal Name: Drug Metabolism and Personalized Therapy Volume: 33 Issue: 3 Pages: 109-118
Source: Drug Metabolism and Personalized Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Genetics